舒巴坦在人体内的药代动力学。
Pharmacokinetics of sulbactam in humans.
作者信息
Foulds G, Stankewich J P, Marshall D C, O'Brien M M, Hayes S L, Weidler D J, McMahon F G
出版信息
Antimicrob Agents Chemother. 1983 May;23(5):692-9. doi: 10.1128/AAC.23.5.692.
Abstract
Sulbactam, a new beta-lactamase inhibitor, has pharmacokinetic characteristics in humans similar to those of ampicillin and amoxicillin. Its half-life in humans is approximately 1 h. In a two-compartment pharmacokinetic model, the apparent volume of distribution for the central compartment is approximately 12 liters, and half of the dose is found in the central compartment in the postdistributive phase. Approximately 75% of a parenteral dose is excreted unchanged in urine. The coadministration of sulbactam with ampicillin, penicillin G, or cefoperazone has essentially no effect upon the kinetics of either the beta-lactam antibiotic or sulbactam.
摘要
舒巴坦是一种新型β-内酰胺酶抑制剂，其在人体内的药代动力学特征与氨苄西林和阿莫西林相似。它在人体内的半衰期约为1小时。在二室药代动力学模型中，中央室的表观分布容积约为12升，在分布后阶段，一半的剂量存在于中央室。静脉注射剂量的约75%以原形经尿液排泄。舒巴坦与氨苄西林、青霉素G或头孢哌酮合用对β-内酰胺类抗生素或舒巴坦的动力学基本没有影响。
相似文献
1
Pharmacokinetics of sulbactam in humans.舒巴坦在人体内的药代动力学。
Antimicrob Agents Chemother. 1983 May;23(5):692-9. doi: 10.1128/AAC.23.5.692.
2
The parenteral kinetics of ampicillin/sulbactam in man.氨苄西林/舒巴坦在人体中的肠胃外动力学。
Int J Clin Pharmacol Res. 1985;5(2):79-86.
3
Pharmacokinetics of sulbactam/ampicillin in humans: a review.舒巴坦/氨苄西林在人体内的药代动力学：综述
Rev Infect Dis. 1986 Nov-Dec;8 Suppl 5:S503-11. doi: 10.1093/clinids/8.supplement_5.503.
4
Pharmacokinetics and bioavailability of sultamicillin estimated by high performance liquid chromatography.用高效液相色谱法估算舒他西林的药代动力学和生物利用度。
J Antimicrob Chemother. 1983 May;11(5):435-45. doi: 10.1093/jac/11.5.435.
5
Sulbactam kinetics and excretion into breast milk in postpartum women.舒巴坦在产后女性中的动力学及向母乳中的排泄情况。
Clin Pharmacol Ther. 1985 Dec;38(6):692-6. doi: 10.1038/clpt.1985.247.
6
Pharmacokinetics of sulbactam and ampicillin following oral administration of sultamicillin with probenecid.口服舒他西林并合用丙磺舒后舒巴坦和氨苄西林的药代动力学
Eur J Clin Microbiol. 1983 Aug;2(4):340-4. doi: 10.1007/BF02019464.
7
Biliary pharmacokinetics of sulbactam plus ampicillin in humans.舒巴坦加氨苄西林在人体内的胆汁药代动力学。
Rev Infect Dis. 1986 Nov-Dec;8 Suppl 5:S589-92. doi: 10.1093/clinids/8.supplement_5.s589.
8
Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration.同时静脉给药后舒巴坦和氨苄西林的比较药代动力学及组织穿透性
Antimicrob Agents Chemother. 1982 Apr;21(4):565-7. doi: 10.1128/AAC.21.4.565.
9
Pharmacokinetics of sultamicillin in mice, rats, and dogs.舒他西林在小鼠、大鼠和犬体内的药代动力学。
Antimicrob Agents Chemother. 1984 May;25(5):599-602. doi: 10.1128/AAC.25.5.599.
10
Penetration of sulbactam-ampicillin and clavulanic acid-amoxicillin into the pelvic peritoneum.舒巴坦-氨苄西林和克拉维酸-阿莫西林在盆腔腹膜中的渗透情况。
Antimicrob Agents Chemother. 1985 Jul;28(1):165-6. doi: 10.1128/AAC.28.1.165.
引用本文的文献
1
Sulbactam Concentration in Critically Ill Patients with Hospital-Acquired Pneumonia: A Comparisons Stratified by Normal and Augmented Renal Clearance.医院获得性肺炎重症患者的舒巴坦浓度：按正常和增强肾清除率分层的比较
Infect Drug Resist. 2025 Sep 4;18:4731-4739. doi: 10.2147/IDR.S538120. eCollection 2025.
2
treatment strategies: a review of therapeutic challenges and considerations.治疗策略：治疗挑战与考量综述
Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0106324. doi: 10.1128/aac.01063-24. Epub 2025 Jul 9.
3
A Comprehensive Study to Determine the Residual Elimination Pattern of Major Metabolites of Amoxicillin-Sulbactam Hybrid Molecules in Rats by UPLC-MS/MS.采用 UPLC-MS/MS 法全面研究氨苄西林-舒巴坦混合分子在大鼠体内主要代谢物的残留消除模式。
Molecules. 2024 May 7;29(10):2169. doi: 10.3390/molecules29102169.
4
Prediction of Tissue Exposures of Meropenem, Colistin, and Sulbactam in Pediatrics Using Physiologically Based Pharmacokinetic Modeling.应用生理药代动力学模型预测儿科患者体内美罗培南、黏菌素和舒巴坦的组织暴露量。
Clin Pharmacokinet. 2022 Oct;61(10):1427-1441. doi: 10.1007/s40262-022-01161-y. Epub 2022 Aug 10.
5
Combined PK/PD Index May Be a More Appropriate PK/PD Index for Cefoperazone/Sulbactam against in Patients with Hospital-Acquired Pneumonia.对于医院获得性肺炎患者，联合药代动力学/药效学指数可能是头孢哌酮/舒巴坦更合适的药代动力学/药效学指数。
Antibiotics (Basel). 2022 May 23;11(5):703. doi: 10.3390/antibiotics11050703.
6
Cefoperazone-Sulbactam Associated Refractory Seizures.头孢哌酮-舒巴坦相关性难治性癫痫发作
Ann Indian Acad Neurol. 2021 Sep-Oct;24(5):784-786. doi: 10.4103/aian.AIAN_1278_20. Epub 2021 May 11.
7
Sulbactam improves binding property and uptake capacity of glutamate transporter-1 and decreases glutamate concentration in the CA1 region of hippocampus of global brain ischemic rats.舒巴坦可提高谷氨酸转运体-1 的结合特性和摄取能力，并降低全脑缺血大鼠海马 CA1 区的谷氨酸浓度。
Amino Acids. 2021 Nov;53(11):1649-1661. doi: 10.1007/s00726-021-03088-3. Epub 2021 Oct 30.
8
Pharmacokinetics of Non-β-Lactam β-Lactamase Inhibitors.非β-内酰胺类β-内酰胺酶抑制剂的药代动力学
Antibiotics (Basel). 2021 Jun 24;10(7):769. doi: 10.3390/antibiotics10070769.
9
Sulbactam Protects Hippocampal Neurons Against Oxygen-Glucose Deprivation by Up-Regulating Astrocytic GLT-1 via p38 MAPK Signal Pathway.舒巴坦通过p38丝裂原活化蛋白激酶信号通路上调星形胶质细胞谷氨酸转运体-1来保护海马神经元免受氧糖剥夺损伤。
Front Mol Neurosci. 2018 Aug 15;11:281. doi: 10.3389/fnmol.2018.00281. eCollection 2018.
10
Classical β-Lactamase Inhibitors Potentiate the Activity of Daptomycin against Methicillin-Resistant Staphylococcus aureus and Colistin against Acinetobacter baumannii.经典β-内酰胺酶抑制剂增强达托霉素对耐甲氧西林金黄色葡萄球菌的活性以及黏菌素对鲍曼不动杆菌的活性。
Antimicrob Agents Chemother. 2017 Jan 24;61(2). doi: 10.1128/AAC.01745-16. Print 2017 Feb.
本文引用的文献
1
The influence of a new benzoic acid derivative on the metabolism of paraaminosalicylic acid (PAS) and penicillin.一种新型苯甲酸衍生物对对氨基水杨酸（PAS）和青霉素代谢的影响。
Ann Intern Med. 1950 Jul;33(1):18-31. doi: 10.7326/0003-4819-33-1-18.
2
SODIUM AMPICILLIN: ABSORPTION AND EXCRETION OF INTRAMUSCULAR AND INTRAVENOUS DOSES IN NORMAL YOUNG MEN.氨苄西林钠：正常青年男性肌肉注射和静脉注射剂量后的吸收与排泄
Am J Med Sci. 1965 Feb;249:163-71.
3
Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration.同时静脉给药后舒巴坦和氨苄西林的比较药代动力学及组织穿透性
Antimicrob Agents Chemother. 1982 Apr;21(4):565-7. doi: 10.1128/AAC.21.4.565.
4
Penicillanic acid sulfone: interaction with RTEM beta-lactamase from Escherichia coli at different pH values.
Biochemistry. 1981 Jun 23;20(13):3688-95. doi: 10.1021/bi00516a004.
5
Penicillanic acid sulfone: an unexpected isotope effect in the interaction of 6 alpha- and 6 beta-monodeuterio and of 6,6-dideuterio derivatives with RTEM beta-lactamase from Escherichia coli.
Biochemistry. 1981 Jun 23;20(13):3680-7. doi: 10.1021/bi00516a003.
6
CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides.CP - 45,899与青霉素或氨苄青霉素联合用于对抗耐青霉素的葡萄球菌、流感嗜血杆菌和拟杆菌。
Antimicrob Agents Chemother. 1980 Apr;17(4):615-22. doi: 10.1128/AAC.17.4.615.
7
Inhibition kinetics of three R-factor-mediated beta-lactamases by a new beta-lactam sulfone (CP 45899).
Biochim Biophys Acta. 1980 Feb 14;611(2):351-7. doi: 10.1016/0005-2744(80)90071-6.
8
Evaluation of gas and other chromatographic separations of indolic methyl esters.吲哚甲酯的气相色谱及其他色谱分离方法评估。
Anal Biochem. 1967 Sep;20(3):484-94. doi: 10.1016/0003-2697(67)90293-x.
9
Comparative blood levels of hetacillin, ampicillin and penicillin G.海他西林、氨苄西林和青霉素G的血液水平比较。
N Engl J Med. 1966 Sep 22;275(12):635-9. doi: 10.1056/NEJM196609222751203.
10
Automated plate diffusion zone measurement and computerized data handling.
Bull Parenter Drug Assoc. 1973 Jul-Aug;27(4):185-94.
Zotero 插件